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Purpose: The purpose of this study was to report our experience inthe management of acute 
aortic occlusion and to analyze factors that influenced the outcome. 
Methods: This was a retrospective analysis of 48 patients with acute aortic occlusion treated 
over a 19-year period. Presentation i cluded limb ischemia in 34, acute abdomen in four, 
spinal cord compression-like symptoms in eight, and sudden onset of hypertension i  two 
patients. Thrombosis was the cause of acute aortic occlusion in 44, and embolus in four 
patients. Acute thrombosis was associated with underlying atherosclerotic occlusive 
disease in 36 patients. In these, thrombosis was due to low-flow state caused by cardiac 
dysfunction or severe volume depletion. Thrombosed aneurysms caused aortic occlusion 
in two patients. Hypercoagulable state caused thrombosis of relatively normal aorta in six 
patients. Angiography in 39 patients revealed occlusion to be juxtarenal or infrarenal in 
37 and suprarenal in two. Left ventricular function (LVF) was assessed in 42 patients. 
Circulation was restored in 45 (aortofemoral bypass in 22, axUlofemoral bypass in 12, and 
thromboembolectomy in 11). This was not feasible in three patients. Additional surgical 
procedures were required in 29 patients (64%). 
Results: The overall mortality rate was 52% (25 of 48). Of  the 20 patients with severely 
compromised LVF, 17 died (85%). In contrast, only five (23%) deaths occurred among 
22 with good LVF. Among 29 patients who required additional operations, 18 died 
(62%). All four patients with embolic occlusion survived. Patients with normal LVF but 
hypercoagulable state had dismal outcome-only one of the six survived. 
Conclusions: Acute aortic occlusion is infrequent. Presentation may be varied, thus delaying 
diagnosis. Poor LVF, thrombosis of arteries below the inguinal igament or of visceral 
arteries, and "hypercoagulable state" portend ominous prognosis. (J VAsc SURG 
1995;21:567-75.) 
Occurrence of acute occlusion of aorta either 
because of thrombosis or embolism is an infrequent 
clinical entity. Except for a recent report by Dossa et 
al.x many of the large reports of aortic occlusion 
mainly describe chronic occlusion of the abdominal 
aorta (Table 1). 2-7 Chronic aortic occlusion is dearly 
a different disease ntity, and principles of diagnosis 
and management do not apply to the acute aortic 
occlusion. There have been isolated reports of acute 
aortic occlusion describing unusual causes and atypi- 
cal presentation. 8-12 Even when diagnosed promptly, 
management requires thorough understanding ofthe 
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underlying factors that contribute to the develop- 
ment of occlusion. Revascularization by itself does 
not ensure successful outcome in these patients in 
whom this may represent either end-stage cardiovas- 
cular dysfunction or poorly understood derangement 
of coagulation homeostasis} 3isPrevious reports on 
acute aortic occlusion have alluded to the difficulties 
in diagnosis and challenges inmanagement leading to 
poor outcome (Table II).1524 We report a retrospec- 
tive review of 48 patients with acute aortic occlusion 
and propose an algorithm for management (Fig. 1). 
Aortic occlusion caused by trauma, aortic dissection, 
and intraaortic balloon pump were not included in 
this study. Based on a Medline search from 1966 to 
1994, this represents he largest series of acute aortic 
occlusion in the English literature. 
PATIENTS AND METHODS 
Medical records of 48 consecutive patients treated 
for acute aortic occlusion caused by either thrombosis 
or embolism were reviewed. There were a total of  48 
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Table I. Large series reporting aortic occlusion 
Author Period (yrs.) Chronic occlusion (No.) Acute occlusion (No.) 
Dossa I 40 0 46 
Starrett a 23 106 0 
Liddicoat 3 6 64 0 
Corson 4 16 63 5 
McCullough s 17 38 0 
Deriu 6 1 30 0 
Ketonen 7 15 55 0 
patients over a 19-year period (1974 to 1993). 
Twenty-six were women, and 22 were men. Age of 
the patients ranged from 35 to 85 years. 
Clinical presentation. Presentation included 
acute limb ischemia in 34, neurologic deficit simu- 
lating acute spinal cord compression (parcsthesia, 
paresis, paralysis) in eight, abdominal pain in four, 
and acute hypertensive crisis in two patients, both of 
whom had extension of thrombus into the renal 
artery. In the acute ischemia group, 18 had pares- 
thesias, but the ischemic symptoms were more 
pronounced. Twenty-eight patients had significant 
coronary artery disease, and 29 had a history of 
hypertension. Duration of ischemia was less than 8 
hours in 29 patients and more than 8 hours in 14 at 
the time of presentation. The exact onset time of 
symptoms could not be determined in five patients. 
Diagnosis of acute aortic occlusion was delayed from 
10 hours to more than 3 days in all 14 patients with 
clinical presentation ther than limb ischemia. In one 
patient myelography was performed before the 
diagnosis of acute aortic occlusion was made. 
Cause. Except for four patients who had embolic 
occlusion, all the rest had acute aortic thrombosis. In 
all four patients with embolic occlusion, the aorta was 
normal, and emboli originated in the heart. Two of 
these had left ventricular thrombus diagnosed by 
echocardiography. In one patient diagnosis of 
myxoma was made on clinical and histologic studies. 
In this patient myxoma was presumed to have 
originated from the heart even though conventional 
and transesophageal chocardiography results were 
normal. The fourth patient had documented valvular 
heart disease, which was believed to be the source of 
aortic embolus. Among 44 patients with acute aortic 
thrombosis, 36 patients had underlying atheroscle- 
rotic occlusive disease, two had small abdominal 
aortic aneurysms (< 5 cm). In the remaining six 
patients with acute thrombosis of normal aorta, the 
diagnosis of "hypercoagulable state" was eventually 
confirmed by hematologic studies. Cause of sudden 
thrombosis in 36 patients with underlying athero- 
sclerotic occlusive disease was precipitated by low 
flow state (20 patients) caused by dehydration 
(volume depletion because of poor intake, aggressive 
diuresis, or third space fluid loss) or cardiac decom- 
pensation (16 patients) caused by congestive heart 
failure, acute myocardial infarction, or sudden intrac- 
table arrhyttwnias: 
In the subgroup of patients with "hypercoagu- 
lable state," diagnosis of heparin-associated throm- 
bosis in three, protein C deficiency in one, and 
anticardiolipin antibody in one was made. The 
definitive cause of"hypercoagulable state" could not 
be made despite hematologic, immunologic, and 
histochemical studies in the sixth patient. 
Management. Preoperative angiograms were 
obtained in 39 patients. In the remaining nine, 
angiography was not performed because the diagno- 
sis of aortic occlusion was obvious, and ischemia was 
advanced at the time of initial presentation. Angio- 
grams revealed occlusion to be juxtarenal or infrare- 
nal in 37 and suprarenal in two patients. In these two 
patients, aortic dissection was suspected because of 
absent femoral pulses, lack of urine output, and back 
pain. The angiogram helped to make the correct 
diagnosis of suprarenal ortic occlusion. There were 
no cases of visceral emboli n this series. When aortic 
occlusion was seen on angiography, femoral arteries 
were almost always visualized (35 patients). To limit 
the contrast load in this group of physiologically 
fragile patients, no specific attempt was made to 
visualize arteries distal to the femoral arteries once the 
diagnosis of aortic occlusion was made. 
After the diagnosis of aortic occlusion was 
established, patients were immediately given heparin 
while measures were taken to improve their state of 
hydration and cardiovascular function. Flow-directed 
pulmonary artery catheters and radial lines were 
placed to obtain hemodynamic data in 42 patients. 
Left ventricular function was assessed by plotting the 
left ventricular stroke work (LVSW) against pulmo- 
nary capillary wedge pressure (PCWP). Pharmaco- 
logic therapy was initiated on the basis of the position 
of the left ventricular fimction (LVF) in relation to 
the Sarnoff ventricular function curve. 14 This guided 
the operative approach to revascularization. Ex- 
traanatomic bypass was preferred in patients with 
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Table II. Previous reports of acute aortic occlusion: types of operations and mortality rates 
No. of 
Author patients Years Management Mortality (%) 
Bell is 6 10 Aortic opn 100 
Danto I6 9 9 Aortic opn 25 
Johnson 17 7 - Aortic opn 53 
Drager 18 6 3 Axfem 16 
Kornmesser 19 22 10 Aortic opn/Embolectomy 41 
Litooy z° 18 8 Aortic opn/Embolectomy 50 
Pietri 21 10 12 Aortic opn 60 
Webb 22 10 10 Axfem/Aortic opn 50 
Ross z3 26 8 Embolectomy 30 
Bradbury 24 14 9 Aortic opn 14 
Dossa 1 46 40 Aortic opn/Axfem/Embolectomy 35 
Present report 48 19 Aortic opn/Axfem/Embolectomy 52 
opn, Operation; Ax39m , Axillofemoral bypass. 
compromised LVF (LVSW less than 40 gm/m/m 2 
with PCWP of 20 mm Hg or greater). Restoration of 
circulation was achieved in 45 patients; 22 aortofem- 
oral bypasses, 12 axillofemoral bypasses, and 11 
thromboembolectomies (10 transfemoral, 1 aortic) 
were performed. Diffuse atherosclerotic disease man- 
dated primary, bilateral, high lower-limb amputa- 
tion in one patient. Moribund state at presentation 
precluded any intervention i two patients. Simulta- 
neous, sequential, and additional vascular and ex- 
travascular procedures were required in 29 patients. 
These included infrainguinal or infragenicular vascu- 
lar procedures (n = 19), bowel resections (n = 3), 
fasciotomy for compartment syndrome (n = 6), and 
major limb amputations (n = 9). 
RESULTS 
There were 25 deaths (52%). As shown in Table 
III, 20 patients had severely compromised LVF, 17 
of whom died (85%) despite surgical correction of 
acute aortic occlusion. The compromised cardiac 
function in this subgroup did not respond to 
pharmacologic therapy. In contrast, here were only 
five deaths (23%) among 22 patients who had 
adequate LVF at the time of presentation r whose 
LVF improved in the perioperative p riod. Improve- 
ment was defined as LVSW greater than 40 gm/m/m 2 
associated with reduction in PCWP to 20 mm Hg or 
lower. Among 29 patients who required additional 
procedures for limb or visceral ischemia, 18 died 
(62%). Of nine patients who required major limb 
amputations, seven died (78%). Advance distal vessel 
disease in four patients, hypercoagulable state in 
three and irreversible ischemia t the time of initial 
presentation in two were the reasons for amputation. 
Hence, severity of ischemia rather than duration 
appeared to be the influencing factor. Of the 36 
patients with primary atherosclerotic o clusive dis- 
ease, 20 died (55%). The subset of patients with 
normal heart and arteries who had thrombosis of 
their aorta because of clotting diathesis had dismal 
outcome. Only one of the six survived in this group 
(83% mortality rate), and three of the six had limb 
loss, including the surviving patient. Both patients 
with suprarenal ortic occlusion (atherosclerotic d s- 
ease in one and hypercoagulability in the other) died. 
All eight patients who were admitted with symptoms 
of spinal cord involvement had complete resolution 
of neurologic symptoms after restoration of circula- 
tion. All four patients with embofic occlusion sur- 
vived. 
DISCUSSION 
Acute aortic occlusion is an uncommon occur- 
rence judging by the experience of various authors 
who have reported small series seen over extended 
time periods. 14-24 The incidence, hence, must be low 
given that diagnostic techniques such as computed 
tomography and ultrasonography ave become rou- 
tine in treatment of patients 'with vascular disease. 
Contrary to what might be expected, not all 
patients with sudden occlusion of abdominal aorta 
are admitted with symptoms of severe ischemia. This 
was amply demonstrated in our series in which 14 of 
the 48 patients were diagnosed with symptoms other 
than lower extremity ischemia. Eight patients were 
initially believed to have spinal cord disease (either 
compression or infarction). The symptoms in this 
group ranged from sudden onset of lower extremity 
paresthesia to frank paraplegia. Others have re- 
ported similar presentation of acute aortic occlu- 
sion. 7'II'12'25'26 Experimental studies have shown that 
the neurologic manifestations of acute aortic occlu- 
sion do not imply spinal cord infarction but severe 
ischemic neuropathy, z7 All our patients with symp- 
toms of spinal cord dysfunction had total resolution 
of symptoms after restoration of circulation, which 
further supports the reversible nature of the neuro- 
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PATIENTS WITH SUSPECTED ACUTE AORTIC OCCLUSION ] 
CLASSIC SYMPTOMS OF LIMB ISCHEMIA I 
ABSENT FEME~RAL PULSES 
IMMEDIATE HEPARINIZATION 
I ANG'°GR M I 
I 
I EMBOLUS I 
EMOLECTOMY VIA FEMORAL ATHEROSCLEROTIC 
APPROACH OCCLUSIVE DISEASE 
l 1 
PROCEED WITH CARDIAC WORK UP INVASIVE MONITORING 
& LONG-TERM ANTICOAGULATION ASSESS LVF 
ATYPICAL SYMPTOMS 
( PARESTHESIAS, PARALYSIS ) ( ACUTE ABDOMEN ) 
I FEMORALPOLBEBPREBENT I 
CT SCAN & APPROPRIATE NEUROLOGIC WORK TREATMENT OF ACUTE UP & TREATMENT ABDOMEN 
AORTIC THROMBOSIS 
I 
NO EVIDENCE OF 
OCCLUSIVE DISEASE 
[ GOOD LVF ] 
AORTOFEMORAL 
BYPASS 
I POOR LVF I '~  ISCHEMIApRoFOuNDNOT S  
ISCHEMIA THROMBOLYTIC 
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AXILLO BI-FEM 
BYPASS SUCCESSFUL 
I~  UNSUCCESSFUL I 
THROMBECTOMY 
INITIATE 
HEMATOLOGIC 
WORK-UP FOR 
HYPERCOAGULABLE 
STATE 
Fig. 1. Proposed management strategy for patients with acute aortic occlusion. 
logic deficits. However, in a 40-year etrospective 
review of acute aortic occlusion by Dossa et al., 1 
presence of moderate to severe motor or sensory 
deficit was shown to correlate with death. The 
neurologic symptoms in these patients with aortic 
occlusion may mislead the treating physician and 
delay the diagnosis. Major vascular occlusion should 
be considered in the differential diagnosis of any 
patient diagnosed with sudden neurologic deficit. 
When patients are sent for imaging studies uch as 
computed tomography ormagnetic resonance imag- 
ing in pursuit of spinal cord disease, the aorta should 
be assessed when spinal cord study resuks are 
negative. Moore et al.11 have suggested that this may 
obviate the need for further invasive studies uch as 
angiography and will expedite correct diagnosis and 
appropriate management. However, angiography 
should generally be performed in all instances unless 
the patient's clinical condition precludes it. In our 
experience, besides confirming the diagnosis, angi- 
ography played a vital role in assessing and planning 
management. Angiography demonstrated xtension 
of aortic thrombus to the renal artery in two patients 
diagnosed with acute hypertension. Fragmentation 
of embolus to vessels distal to the aortic bifurcation 
was documented bypreoperative angiography in one 
patient, thus guiding appropriate operative proce- 
dure in addition to aortic embolcctomy. Angiogra- 
phy will also help in delineating the status of visceral 
circulation, particularly in those patients admitted 
with symptoms of acute abdomen and absent femoral 
pulses. 
In patients diagnosed with symptoms of lower 
limb ischemia, the degree of manifestations ranged 
from mild (cool extremities) to severe (mottled, 
cyanotic extremities, compartment syndrome, myo- 
necrosis). The threshold for tolerance to sudden 
aortic occlusion was very low in some patients who 
had rapid progression tocompartment syndrome and 
kidney failure, which complicated the management. 
Because of the variability of clinical presentation a d 
the difficulty in establishing the absolute time of 
onset of aortic occlusion, statistical analysis of factors 
predictive of low tolerance to ischemia was not 
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possible. However, patients with hypercoagulable 
state appeared to have the lowest threshold for 
sudden interruption of circulation distal to the aorta. 
This could be explained by thrombosis of microcir- 
culation or the inability of collateral vessels to 
compensate for the acute aortic occlusion (because 
these patients had no preexisting occlusive disease).6 
Only four patients in this series had embolic 
occlusion. Most reports of large series of embolic 
occlusion are from countries where rheumatic heart 
disease is still prevalent. 28When occlusion of the 
aorta is caused by embolism, emboli n the arteries 
distal to the aorta should be ruled out after aortic 
embolectomy is performed. One of our patients 
showed significant improvement of her limb isch- 
emia after aortic embolectomy. However, lack of 
palpable pedal pulse prompted repeat angiography, 
which revealed embolic occlusion of the popliteal 
artery, which was promptly treated. Preoperative 
angiography may not always show distal emboli 
because of poor visualization of distal vessels when 
there is major aortic occlusion. Hence, adequacy of 
embolectomy should be confirmed by intraoperative 
angiography if pedal pulses are not present after 
aortic embolectomy. Whereas most patients with 
embolic occlusion of the aorta may be treated with 
retrograde transfemoral embolectomy, one of our 
patients required direct aortotomy to retrieve an 
embolus that was firmly wedged in the aortic 
bifurcation. All four patients urvived even though 
high mortality rates have been reported in the 
literature for embolic occlusion of the aorta. 2°'2s 
Aortic occlusion was due to thrombosis in 44 
patients. Occlusive vascular disease was the underly- 
ing cause in 36, which was limited to the aorta in 
eight but involved the iliac and femoral arteries and 
distal vessels in 28 patients. When low flow states 
occur, the development of acute thrombosis in 
patients with preexisting chronic vascular disease has 
been noted by others. 14"16'20"22'24 
Abrupt hrombosis ofaneurysms was the cause of 
acute aortic occlusion in two patients, both of whom 
survived without sequelae. Thrombosis of small 
aneurysms, the disastrous consequences of such 
thrombosis, and mortality rates in these patients 
approaching those of ruptured aneurysms have been 
reported, is-iT When patients are admitted with acute 
aortic occlusion, thrombosis of aortic aneurysms 
should be considered in the differential diagnosis. 
Abnormal clotting diathesis has only recently 
been described as a cause of acute aortic thrombo- 
sis. 13,29 Detailed hematologic evaluation should be 
performed in any patient diagnosed with acute aortic 
thrombosis who is free of heart or vascular occlusive 
disease. 
Table III. Acute aortic occlusion: factors 
affecting outcome 
No. of Mortality 
Factors patients (%) 
Good LVF 22 5 (23) 
Fairing ventricle 20 17 (85) 
Additional procedures 29 18 (62) 
Limb amputations 9 7 (78) 
Hypercoagulable state 6 5 (83) 
Embolic occlusions 4 0 (0) 
LVF, Left ventricular function. 
Preoperative management, including administra- 
tion of heparin, hydration, and optimization of 
cardiac function, are as important as the operative 
intervention for successful outcome. We have previ- 
ously reported the significance of such monitor- 
guided responses in the treatment of critically ill 
patients? ° When the data obtained by invasive 
monitoring revealed suboptimal LVF, the operative 
approach was modified if feasible. Extraanatomic 
bypasses were performed preferentially. Drager et 
al. 18 have recommended the routine use of axil- 
lofemoral bypass in the treatment of patients with 
acute aortic occlusion. Extraanatomic bypasses have 
lower patency rates and, hence, may not be ideal for 
all patients. We believe that direct aortic reconstruc- 
tion is preferable in those patients whose LVF is 
adequate or who have evidence of renal or mesenteric 
involvement associated with acute aortic thrombosis. 
Both femoral arteries should be exposed initially 
because femoral arteries are the site of distal anasto- 
mosis whether the inflow is chosen to be the aorta or 
axillary artery. Thrombectomy should be attempted 
by the femoral approach. This is the procedure of 
choice in those patients with acute aortic thrombosis 
or embolism and no evidence of preexisting occlusive 
disease. No patients in our series were treated by 
thrombolysis, although recent reports have proved 
both the safety and efficacy of thrombolytic therapy 
in infants and adults. 31,a2 This may be preferable 
therapy in patients with acute aortic thrombosis 
caused by "hypercoagulable state" because this subset 
of patients fared poorly with surgical intervention 
despite normal arteries and good LVF. 
There were 25 deaths among 48 patients, ac- 
counting for an overall mortality rate of 52%. 
Previous reports have highlighted the high mortality 
rate associated with acute aortic thrombosis (Table 
II). Seventeen of 20 patients (85%) with severely 
compromised LVF died, in contrast to five deaths 
among 22 (23%) patients with good LVF. It appears 
that acute thrombosis of the aorta represented the 
terminal event in the subgroup of patients with 
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advanced vascular disease and failing heart. Retro- 
spectively, hypercoagulable state, atherosclerotic dis- 
ease extending beyond the aortoiliac segment, and 
intractable heart failure all appeared to be clues to the 
necessity for additional operative interventions. 
Acute aortic occlusion is an infrequent occur- 
rence. Symptoms other than limb ischemia at the 
time of presentation may mislead the treating phy- 
sician and delay the diagnosis in as much as one third 
of patients. Once the diagnosis is made, therapy 
should be based on sound clinical judgment sup- 
ported by hemodynamic parameters. The manage- 
ment spectrum ranges from simple thromboembo- 
lectomy, extraanatomic bypass, and aortic recon- 
struction to thrombolytic therapy. Based on our 
experience and a review of the literature spanning 
three decades, we propose a systematic approach to 
the evaluation and treatment of these critically ill 
patients (Fig. 1). The disappointing outcome in 
patients with "hypercoagulable state" underscores 
the need for further research into the factors that 
derange coagulation homeostasis. 
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DISCUSSION 
Dr. William C. Mackey (Boston, Mass.). The authors 
have presented a large, skillfully treated, and carefully 
analyzed series of 48 patients with acute embolic or 
thrombotic abdominal aortic occlusion. Notable is their 
finding that nearly one third of these patients are diagnosed 
with symptoms other than acute limb ischemia. The eight 
patients diagnosed with neurologic symptoms are espe- 
cially interesting and should increase our awareness of this 
clinical scenario. Also notable is the lethality of this 
condition. Even with state-of-the-art resuscitation, moni- 
toring, hemodynamic support, and surgical management, 
more than half of their patients in their series died. 
Correlates of death in their patients were poor ventricular 
function; the extent of ischemia, vascular disease, or 
end-organ damage at presentation asmeasured by the need 
for ancillary procedures; and the presence of hypercoagu- 
lability. 
Why did you choose not to include aortic occlusion 
caused by an intraaortic balloon pump (IABP) or dissec- 
tion? The comorbidity factors, management guidelines, 
and outcome in these patients hould not be very different 
from those in the 48 patients you did analyze. How many 
IABP and dissection occlusions were there during your 
18-year study period and what was their outcome? 
Your series spans 18 years. How has your treatment of 
these patients changed over this period? Have your 
management changes resulted in improved survival rates? 
From an economic and outcomes analysis viewpoint, 
these patients undoubtedly represent a disaster. Based on 
your current understanding of these patients, can with- 
holding care be justified? Can patients whose likelihood of 
survival is nil be identified before therapy? 
Finally, do you have any follow-up data on your 
survivors? If the acute survivors have very poor long-term 
survival rates, intervention with its extensive resource 
allocation and 52% acute mortality rate, may be difficult to 
justify. On the other hand, if long-term survival is excellent, 
as in patients diagnosed with chronic limb ischemia because 
of aortoiliac disease, intervention can be more easily 
defended. 
Dr. Sateesh C. Babu. Regarding use of the IABP, we 
treated three or four patients. We did not include them 
because this condition was partly iatrogenic and partly due 
to preexisting disease. The outcome in this subset was poor 
because of delay in therapy because of these cardiac 
complications. 
We did not have any patients with trauma, although 
there have been written reports of aortic occlusion caused 
by trauma, so that was excluded. 
Regarding improvement of results in these 18 years, 
our results have not shown improvement. The surgical 
principles and the physiologic monitoring have not 
changed in our hands during this time span. 
Whether we should select which patients should 
undergo surgical therapy is a difficult dilemma. For 
example, the last patient we did not operate on had 
extensive ischemia from the umbilicus down to the toes, 
which we call premortem rigor mortis. Our decision ot to 
operate was a difficult one and hard to extrapolate to 
general guidelines. 
The real reason our results have not improved is due to 
poor control ofthrombogenesis. The hypercoagulable state 
was the major challenge for us. These patients were 
frequently oung patients with normal-looking arteries; 
however, within a few hours after surgical thrombectomy, 
they were thrombosed again. I do not think that we have 
the full answer of how to treat these patients. 
Regarding follow-up, I have to say those patients 
whom we successfially operated on are all doing well. In 
fact, we are still monitoring some of them, although I
do not have the exact number to give you. Those pa- 
tients on whom we operated are doing well. Should we 
perform axillofemoral bypass routinely in these people? 
Some patients had active peritonitis as a presenting picture, 
and we had to explore the abdomen to make sure that 
they did not have associated ischemic bowel or some other 
problems. 
Dr. Enrico Ascer (Brooklyn, N.Y.). I share the same 
anxiety and frustration in treating these patients who are 
very sick; we try to do a quick thrombectomy or 
embolectomy and think that's enough. However, we have 
learned acouple of lessons the hard way over the years. One 
is that, after the embolectomy, we have to be sure that our 
inflow is sufficient, because many of these patients will have 
thrombosis the next day, and we think that it was an 
inadequate thrombectomy when actually the patients had 
underlying disease. So we routinely measure pressures in 
the femoral artery. The other lesson that we have learned, 
which has accounted for the good results over the last 3 or 
4 years when we had 16 patients with only one death, is that 
we have been very aggressive about doing axillobifemoral 
bypasses after the first embolectomy. In the operating 
room, if the pressures are not good and our completion 
angiogram is not satisfactory, we perform axillobifemoral 
bypass. But we also learned that preoperative arteriograms 
are very helpful in evaluation of these patients, not only to 
confirm and try to delineate the outflow, but more 
importantly to examine the inflow vessels for an axillofemo- 
ral bypass. So these are lessons that have helped us over the 
last 3 or 4 years to improve our results. 
Dr. Babu. I agree with you, particularly about defining 
the inflow when you perform axillofemoral bypass. I also 
have stressed that thrombectomy usually is uniformly 
unsuccessful if there is preexisting vascular disease. So we 
advocate some form of vasoalar econstruction such as 
aortofemoral or axillofemoral bypass grafts. We did not 
discuss the selection of aortic reconstruction versus axil- 
lofemoral bypass based on an evaluation of ventricular 
function. For patients with poor ventricular function, one 
should expose both femoral arteries, try to do a thrombec- 
tomy, and, if it fails, proceed immediately to axillofemoral 
bypass in these patients. 
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Dr. Keith D. Calligaro (Philadelphia, Pa.). Can you 
assess the role of lyric treatment in these patients, assuming 
you do not have to do a laparotomy for other intraabdomi- 
nal findings and assuming the legs are not that acutely 
ischemic where you think you might have a few hours. 
My second question has to do with the hypercoagulable 
states you mentioned about he heparin. You state that the 
heparin was the cause of the arterial thrombosis. Why 
should the patients have been receiving heparin unless they 
were in the hospital for other reasons? 
Dr. Babu. The hypercoagulable state was confirmed 
only after the fact. This was a patient who had a transient 
ischemic attack, was given heparin by the neurologist, and, 
within about 6 hours, presented with severe ischemia on 
the lower half of the body. We immediately tried to do a 
thrombectomy, administered more heparin, and were 
unsuccessful. Twenty-four hours later the hematologist 
confirmed that this patient had heparin-associated hrom- 
bosis. This patient exemplifies a major problem when we 
have a hypercoagulable state, we do not know this until 
after the fact. Therefore we use an algorithm in those 
patients diagnosed with sudden aortic thrombosis n whom 
we do not suspect apreexisting vasaalar disease, or who do 
not have heart disease. These patients may have a hyper- 
coagulable state, and we may need to think of alternative 
treatments other than surgery. 
With regard to your second point of thrombolytic 
therapy, none of our patients had thrombolytic therapy, 
although there are three or four cases in the literature of 
successful treatment of aortic thrombosis with throm- 
bolytic therapy, and we have included it in our algorithm. 
Some patients who do not have ischemia when they are 
admitted may be candidates for thrombolytic therapy, 
particularly in the hypercoagulable group. 
Dr. Jonathan P. Gertler (Boston, Mass.). We pro- 
spectively examined coagulation parameters in a variety of 
patients after vascular surgery. Routinely there is derange- 
ment in fibrinolytic function and coagulation function 
resulting in a procoagulant s ate. It turns into an uncer- 
taint,/principle because you are measuring patients after 
surgery and therefore you may detect acute changes in 
coagulation that do not reflect he underlying state of the 
patient. Heparin-induced thrombocytopenia h s been 
mentioned, and these patients must have been hospitalized. 
Are other patients in your hypercoagulable group a/so 
hospitalized before aortic occlusion? 
Dr. Moshe Haimov (New York, N.Y.). These patients 
frequently present with severe spinal cord dysfunction. 
What is your experience about the reversibility of that 
dysfunction in the patients who survive? Would aortic 
reconstruction where you can open the lumbar circulation 
be better for a patient like this than axillobifemoral where 
you leave the cord ischemic? 
Dr. Babu. It is interesting that the neurologic deficit 
was previously believed to be due to spinal cord ischemia 
in aortic thrombosis. However, this does not appear to be 
true. Several experimental studies have shown that the 
neurologic picture that we see in acute aortic infrarenal 
occlusion is different han the picture in thoracic aortic 
occlusion or dissection. The neurologic picture after 
infrarenal aortic occlusion is actually an intense ischemic 
neuropathy that is totally reversible. All eight patients in 
our series had reversible neurologic deficits. What we need 
to keep in mind is that these patients did not present 
with severe ischemia initially, but with neurologic symp- 
toms. In fact, one or two of these patients even underwent 
myelography with the assumption that this was actually a 
spinal cord problem. 
Dr. Syde A. Taheri (Buffalo, N.Y.). Heparin- 
associated thrombosis is an extremely rare condition, 
perhaps 3% of cases, and therefore we are dealing with 
positive antibody in probably 95% of our cases. If our 
patients don't respond to heparin, should we add some 
steroids to this treatment? 
Dr. Babu. It is tough to say. As Dr. Gertler pointed 
out, the diagnosis ofhypercoagulable state is not easy. This 
diagnosis ometimes takes 10 to 15 days to establish, with 
our rheumatologists and hematologists working together. 
Antiphospholipid antibody was confirmed in one patient, 
but it would be difficult to know beforehand, and I do 
not know whether the steroids will help just on the basis 
of suspicion. One of the patients in whom we were unable 
to determine the exact nature of hypercoagulable state was 
given azathioprim on the assumption that this was an 
immune problem, but he continued to have intravascular 
thrombosis. 
Dr. Thomas S. Riles (New York, N.Y.). The group 
that is hypercoagulable is separate from the others, and I 
have little experience with it. My experience at the time we 
wrote our study was that the vast majority of these patients 
have some underlying heart problem, and that is usually 
what precipitates it. Either they had a myocardial infarc- 
tion, they had the embolus from the heart, or they were 
overly treated by the cardiologists, which makes their 
condition very unstable at the time that you see them; this 
is why I think your options are somewhat limited. 
Although you still recommend angiography, out of 
how many patients did the angiogram really give you useful 
information? If the patient is making ood urine and has no 
pulses and has obviously ischemic limbs, you can figure out 
from that that the occlusion is in the infrarenal aorta. In 
fact, our experience has been that, if the angiogram is 
obtained above the occlusion, there is a high incidence of 
renal insufficiency because of their underlying condition 
and also that all of the dye is going into the renal arteries. 
Therefore we go straight to the operating room, cut down 
on the femoral arteries, pass the Fogarty catheters, and 
perform axillobifemoral grafting. Usually we like the 
sequence of diagnosis, angiography, and then surgery. 
However, this is one situation that has to be treated as an 
emergency, and the primary goal is to restore flow to the 
lower limbs as soon as possible. 
Dr. Babu. I agree with you. When the diagnosis is 
certain, we probably do not need the angiogram. Whether 
JOURNAL OF VASCULAR SURGERY 
Volume 21, Number 4 Babu et al. 575 
we do a thrombectomy or whether we are going to do an 
aortofemoral or axillofemoral bypass, the femoral arteries 
will be the common outflow tract, so I agree that the 
femoral arteries should be exposed first. However, the 
diagnosis was not always certain. Fourteen patients had the 
diagnosis much in doubt because their presentation was 
very unusual. With present day arterial digital techniques, 
very little dye is used, and, perhaps if you have the 
convenience of doing it quickly, you would still prefer to 
obtain the angiogram to know that you are not missing 
something. For example, if it was an aortic dissection, the 
whole management would be different. 
Dr. Clark E. Williamson (Philadelphia, Pa.). I am 
interested inyour patients who had hypercoagulable states. 
I had a patient who had an aortic occlusion the first night 
after aortobifemoral bypass who had no technical problems 
when we transected the aorta, had white thrombus itting 
in the aortic stump, and later was documented to have 
heparin-induced thrombocytopenia. The only way we were 
able to save that patient was to obtain some ancrod and 
prevent clotting. We were able to save the patient's life at 
that point. So have you had any experience with this 
medication in this subgroup of patients with a hyperco- 
agulable state? 
Dr. Babu. That is very interesting information. We 
were not able to make the diagnosis so rapidly. We 
diagnosed this heparin-associated thrombosis later, by 
which time this patient had already lost a limb. If we have 
a high index of suspicion, we may use either thrombolytic 
therapy or ilioprosts. 
Dr. John J. Ricotta (Buffalo, N.Y.). It is a little 
dangerous to say that these neurologic problems are always 
completely reversible. 
How often did you perform fasciotomies in these 
patients? Do you have any suggestions about how to 
manage the legs? How do you treat these patients with 
heparin-induced thrombocytopenia? I treated several pa- 
tients who ended up undergoing amputation. 
Dr. Babu. I agree with you that there are some 
literature suggesting that paraplegia or the neurologic 
deficit has been irreversible in acute aortic occlusion. But in 
these eight patients in our series, all of them had reversible 
neurologic deficits. So the neurologic deficit should not be 
considered as a factor that will determine not to offer 
therapy in this disease. In most patients it is not due to 
spinal cord ischemia but to intense peripheral ischemia fter 
acute arterial occlusion. 
Regarding fasciotomy, we have become more sensitive 
to it now in aortic occlusion. We found that younger 
patients and those with hypercoagulable state were in fact 
less tolerant o acute aortic occlusion rather than the older 
patients with preexisting disease. More likely, however, the 
explanation is that the older cohort of patients already had 
collateral vessels, and so they tolerated the aortic occlusion 
better than the young patients who had no established 
collateral vessels. Furthermore, the younger patients who 
had a hypercoagulable state also had clotting of their 
collateral vessels, making them the patients most difficult o 
treat. To answer your question directly, the fasciotomy is
done only when we see that the leg compartment swells 
after restoration of circulation, or 'when we have a high 
index of suspicion. 
If we do not restore pulses after aortic thrombectomy 
or axillofemoral bypass, we obtain an intraoperative 
angiogram to make sure that there are no distal thrombi or 
emboli that can be completely missed in the initial 
angiogram. 
Dr. Glen R. Rhodes (Fairfax, Va.). I reported the first 
patient with heparin-induced thrombocytopenia in 1973. 
My sense in watching this over a period of time is that, 
other than trying to exceed some kind of controlled throm- 
bolytic state, either in the patient who has been recognized 
to have development of the platelet drop, or the patient 
who had development ofthrombosis, there really is no way 
out for this type of problem. The Canadians in fact have had 
a lot of experience intrying to give thrombolysis to patients 
who had development ofa platelet drop without hrombo- 
sis just to get them out of the situation because there is no 
lead way in terms of stopping administration of heparin 
once the platelet count starts to drop. Medicolegally ou 
have to stop administration of heparin. Therefore, in the 
patient who has not had development ofthrombosis, if you 
can give urokinase or some other lytic agent, it may allow a 
transition to warfarin (Coumadin) to be able to manage 
that potential hypercoagulability once you stop the hepa- 
tin. If you already had thrombosis, 'you can try a variety of 
things, including dextran, but you will eventually have to 
administer Coumadin when you need a transition. I think 
we are developing an increasing ability to manage uroki- 
nase during operation; but I think we are going to develop 
new techniques for urokinase or some other kind ofthrom- 
bolytic agent during operation in patients with drains, with 
reoperations, to try to determine whether we can achieve 
survival. But I see no other way to try to get a transition 
with a fibrolytic agent or some other antihypercoagulable 
agent o be able to have any increased survival rate. 
